V
Verified Peptides
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | A | 4 | 8.3 | 7.9 | 8.9 | 13 Feb 2025 |
| Tirzepatide | A | 4 | 7.2 | 7.0 | 7.5 | 13 Feb 2025 |
| Melanotan II | B | 4 | 7.1 | 6.0 | 8.4 | 19 Feb 2025 |
| Retatrutide | B | 4 | 7.0 | 5.9 | 9.7 | 13 Feb 2025 |
| PT-141 | B | 4 | 6.5 | 5.9 | 7.0 | 16 Mar 2025 |
| BPC-157 | B | 5 | 6.7 | 5.2 | 9.0 | 14 Jan 2025 |
| Ipamorelin | C | 4 | 5.6 | 4.9 | 6.9 | 13 Feb 2025 |
| CJC-1295 | C | 5 | 6.8 | 4.1 | 8.4 | 14 Jan 2025 |
| Abaloparatide | A | 2 | 7.2 | 6.9 | 7.6 | 17 May 2026 |
| ACE-031 | A | 2 | 7.0 | 5.9 | 8.1 | 19 Jan 2026 |
| Anadrol (Oxymetholone) | X | 1 | 4.0 | 4.0 | 4.0 | 14 Jan 2025 |
| Anavar (Oxandrolone) | A | 2 | 10.0 | 10.0 | 10.0 | 25 May 2026 |
| Arimidex (Anastrozole) | X | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 |
| Aromasin (Exemestane) | A | 3 | 7.1 | 3.5 | 9.2 | 17 May 2026 |
| BAM15 | A | 3 | 5.2 | 3.8 | 6.3 | 23 May 2026 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | A | 3 | 6.3 | 4.5 | 8.8 | 24 May 2026 |
| Cerebrolysin | A | 3 | 8.3 | 7.3 | 10.0 | 24 May 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | A | 3 | 7.4 | 6.7 | 8.2 | 26 Jan 2026 |
| Dapoxetine | X | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 |
| DHB (1-Test Cyp) Oral | A | 2 | 7.0 | 5.7 | 8.3 | 25 May 2026 |
| Dihexa | A | 2 | 6.5 | 6.1 | 6.9 | 23 May 2026 |
| EPO | A | 2 | 6.9 | 6.2 | 7.6 | 21 May 2026 |
| KPV Oral | A | 2 | 8.6 | 7.8 | 9.4 | 26 Jan 2026 |
| KPV | A | 3 | 6.7 | 5.7 | 8.2 | 26 Jan 2026 |
| Letrozole | A | 2 | 7.8 | 7.6 | 7.9 | 21 May 2026 |
| Lipo-B 216mg | A | 2 | 7.6 | 6.3 | 8.8 | 19 Jan 2026 |
| Liraglutide | X | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 |
| Minoxidil Oral | A | 3 | 8.8 | 8.3 | 9.4 | 24 May 2026 |
| MOTS-C | A | 2 | 7.5 | 6.6 | 8.4 | 23 May 2026 |
| MT-1 | A | 2 | 7.8 | 7.6 | 8.0 | 17 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | A | 3 | 6.3 | 4.7 | 7.2 | 21 May 2026 |
| NAD+ | A | 2 | 7.5 | 7.5 | 7.6 | 26 Jan 2026 |
| Oxytocin Acetate | A | 3 | 7.1 | 6.0 | 8.0 | 24 May 2026 |
| P21 | X | 1 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 |
| Primobolan Oral (Methenolone Acetate) | A | 2 | 7.0 | 6.1 | 8.0 | 17 May 2026 |
| Selank 10mg + Semax 10mg Blend | A | 3 | 5.9 | 5.7 | 6.2 | 17 May 2026 |
| Selank | A | 2 | 6.8 | 5.3 | 8.4 | 23 May 2026 |
| Semax | A | 2 | 8.2 | 8.1 | 8.3 | 19 Jan 2026 |
| Super Shred | A | 2 | 6.7 | 5.4 | 8.0 | 23 May 2026 |
| Tamoxifen (Nolvadex) Raw | A | 2 | 7.8 | 6.3 | 9.3 | 17 May 2026 |
| Tamoxifen (Nolvadex) | A | 2 | 6.3 | 5.8 | 6.8 | 24 May 2026 |
| Testosterone Phenylpropionate Raw | A | 2 | 6.8 | 6.0 | 7.5 | 17 May 2026 |
| Tirzepatide Raw | X | 1 | 7.9 | 7.9 | 7.9 | 16 Mar 2025 |
| Tren Hex | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 |
| Winstrol (Stanozolol) | A | 3 | 6.3 | 5.3 | 7.4 | 23 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | BAM15 | 4.0 | 50mg | 46.4mg | -7.1% | 96.95% | Lab C |
| 24 May 2026 | Dihexa | 4.0 | 10mg | 11.8mg | +17.8% | 98.89% | Lab F |
| 24 May 2026 | Tirzepatide Raw | 8.4 | 100g | 99.7g | -0.3% | 98.36% | Lab F |
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.1 | 2mg | 2.3mg | +13.6% | 99.04% | Lab F |
| 24 May 2026 | MOTS-C | 8.4 | 10mg | 10.0mg | -0.3% | 96.98% | Lab A |
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.3 | 10mg | 12.4mg | +23.8% | 96.47% | Lab G |
| 24 May 2026 | Dapoxetine | 10.0 | 10mg | 12.2mg | +22.0% | 98.19% | Lab E |
| 24 May 2026 | Dihexa | 7.1 | 100mg | 103.9mg | +3.9% | 97.23% | Lab D |
| 24 May 2026 | KPV Oral | 8.3 | 10mg | 11.7mg | +16.8% | 96.94% | Lab G |
| 24 May 2026 | KPV | 7.4 | 30mg | 33.4mg | +11.2% | 95.03% | Lab D |
| 24 May 2026 | EPO | 7.1 | 10mg | 12.0mg | +19.9% | 96.22% | Lab F |
| 24 May 2026 | MT-1 | 8.5 | 30mg | 31.3mg | +4.3% | 97.44% | Lab A |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 8.3 | 25mg | 23.2mg | -7.3% | 98.27% | Lab F |
| 23 May 2026 | Oxytocin Acetate | 6.4 | 10mg | 9.4mg | -6.2% | 99.55% | Lab D |
| 23 May 2026 | Tamoxifen (Nolvadex) Raw | 7.5 | 1g | 1.0g | -1.5% | 98.25% | Lab G |
| 23 May 2026 | Abaloparatide | 8.2 | 2mg | 2.1mg | +6.7% | 97.43% | Lab D |
| 23 May 2026 | KPV | 8.0 | 50mg | 60.8mg | +21.6% | 97.20% | Lab B |
| 21 May 2026 | Aromasin (Exemestane) | 7.9 | 100mg | 103.0mg | +3.0% | 98.60% | Lab A |
| 21 May 2026 | Cerebrolysin | 6.6 | 2mg | 1.7mg | -13.5% | 97.94% | Lab F |
| 21 May 2026 | EPO | 8.6 | 15mg | 18.5mg | +23.5% | 96.50% | Lab G |
| 21 May 2026 | KPV | 7.4 | 50mg | 62.4mg | +24.8% | 99.39% | Lab G |
| 21 May 2026 | Tamoxifen (Nolvadex) Raw | 7.4 | 500g | 605.2g | +21.0% | 96.83% | Lab A |
| 21 May 2026 | Minoxidil Oral | 7.9 | 100mg | 115.1mg | +15.1% | 95.23% | Lab G |
| 21 May 2026 | Minoxidil Oral | 9.6 | 20mg | 24.3mg | +21.4% | 97.45% | Lab B |
| 21 May 2026 | Tren Hex | 6.3 | 200mg/ml | 200.9mg/ml | +0.4% | 95.37% | Lab B |
| 20 May 2026 | Arimidex (Anastrozole) | 6.7 | 20mg | 20.1mg | +0.5% | 97.85% | Lab C |
| 20 May 2026 | Aromasin (Exemestane) | 8.7 | 50mg | 49.0mg | -1.9% | 95.88% | Lab G |
| 20 May 2026 | MT-1 | 8.0 | 20mg | 24.6mg | +22.8% | 96.69% | Lab E |
| 19 May 2026 | Anavar (Oxandrolone) | 9.2 | 50mg | 56.4mg | +12.7% | 96.29% | Lab E |
| 19 May 2026 | Lipo-B 216mg | 7.4 | 250mg/ml | 286.2mg/ml | +14.5% | 97.82% | Lab B |
| 19 May 2026 | Liraglutide | 7.1 | 15mg | 17.5mg | +16.3% | 99.66% | Lab G |
| 19 May 2026 | P21 | 5.7 | 5mg | 5.9mg | +17.6% | 98.36% | Lab G |
| 17 May 2026 | Aromasin (Exemestane) | 7.3 | 100mg | 92.8mg | -7.2% | 98.98% | Lab G |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.5 | 30mg | 32.4mg | +7.9% | 97.17% | Lab D |
| 17 May 2026 | NAD+ | 7.3 | 30mg | 31.6mg | +5.5% | 99.38% | Lab E |
| 17 May 2026 | Selank 10mg + Semax 10mg Blend | 7.4 | 10mg | 9.6mg | -4.0% | 98.82% | Lab B |
| 17 May 2026 | Testosterone Phenylpropionate Raw | 6.7 | 10g | 10.4g | +4.0% | 97.83% | Lab E |
| 29 Jan 2026 | Anavar (Oxandrolone) | 8.0 | 100mg | 122.8mg | +22.8% | 95.01% | Lab C |
| 29 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 5.7 | 200mg/ml | 245.7mg/ml | +22.8% | 97.81% | Lab E |
| 29 Jan 2026 | Tamoxifen (Nolvadex) | 5.3 | 100mg | 124.3mg | +24.3% | 99.40% | Lab C |
| 26 Jan 2026 | BAM15 | 5.1 | 20mg | 23.8mg | +19.0% | 97.27% | Lab B |
| 26 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.0 | 100mg/ml | 91.1mg/ml | -8.9% | 96.33% | Lab D |
| 26 Jan 2026 | DHB (1-Test Cyp) Oral | 6.9 | 100mg | 103.7mg | +3.7% | 98.18% | Lab B |
| 26 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.2 | 5mg | 5.6mg | +12.1% | 97.94% | Lab D |
| 26 Jan 2026 | Winstrol (Stanozolol) | 4.0 | 25mg | 22.2mg | -11.2% | 95.69% | Lab E |
| 19 Jan 2026 | BAM15 | 7.1 | 10mg | 8.5mg | -15.0% | 99.13% | Lab C |
| 7 Jan 2026 | Cerebrolysin | 8.2 | 15mg | 15.4mg | +2.6% | 98.52% | Lab A |
| 7 Jan 2026 | Lipo-B 216mg | 9.0 | 300mg/ml | 338.4mg/ml | +12.8% | 96.21% | Lab C |
| 7 Jan 2026 | Super Shred | 5.7 | 300mg/ml | 262.4mg/ml | -12.5% | 99.30% | Lab A |
| 6 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 6.7 | 100mg | 118.4mg | +18.4% | 95.43% | Lab G |
| 6 Jan 2026 | Selank | 8.5 | 2mg | 2.0mg | -1.9% | 97.92% | Lab G |
| 29 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.7 | 20mg | 17.3mg | -13.3% | 95.38% | Lab B |
| 29 Dec 2025 | Semax | 7.6 | 10mg | 8.6mg | -14.0% | 98.36% | Lab E |
| 12 Dec 2025 | NAD+ | 10.0 | 2mg | 2.0mg | -1.9% | 97.18% | Lab D |
| 12 Dec 2025 | Oxytocin Acetate | 6.4 | 30mg | 29.4mg | -2.1% | 99.41% | Lab E |
| 12 Dec 2025 | Semax | 8.5 | 10mg | 11.6mg | +15.5% | 95.10% | Lab G |
| 12 Dec 2025 | Testosterone Phenylpropionate Raw | 6.2 | 1g | 1.2g | +21.4% | 98.22% | Lab E |
| 5 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.3 | 15mg | 14.6mg | -3.0% | 96.02% | Lab E |
| 5 Dec 2025 | Tamoxifen (Nolvadex) | 5.6 | 25mg | 24.6mg | -1.8% | 99.96% | Lab E |
| 23 Nov 2025 | MOTS-C | 5.6 | 2mg | 2.3mg | +15.4% | 98.71% | Lab C |
| 17 Nov 2025 | ACE-031 | 8.6 | 2mg | 2.1mg | +4.3% | 99.94% | Lab B |
| 17 Nov 2025 | ACE-031 | 4.2 | 10mg | 8.5mg | -14.8% | 99.06% | Lab D |
| 17 Nov 2025 | Letrozole | 8.1 | 50mg | 56.9mg | +13.8% | 99.93% | Lab C |
| 17 Nov 2025 | Minoxidil Oral | 6.6 | 50mg | 53.2mg | +6.5% | 95.67% | Lab F |
| 17 Nov 2025 | Super Shred | 5.6 | 200mg/ml | 196.6mg/ml | -1.7% | 98.33% | Lab D |
| 14 Nov 2025 | Cerebrolysin | 6.5 | 20mg | 21.7mg | +8.5% | 98.70% | Lab C |
| 14 Nov 2025 | DHB (1-Test Cyp) Oral | 6.7 | 100mg | 113.7mg | +13.7% | 99.57% | Lab D |
| 14 Nov 2025 | Letrozole | 7.8 | 25mg | 27.4mg | +9.6% | 99.38% | Lab F |
| 14 Nov 2025 | Winstrol (Stanozolol) | 5.1 | 10mg | 10.7mg | +6.8% | 98.05% | Lab D |
| 5 Nov 2025 | Anadrol (Oxymetholone) | 4.0 | 20mg | 19.9mg | -0.5% | 96.86% | Lab G |
| 5 Nov 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.9 | 300mg/ml | 322.5mg/ml | +7.5% | 99.98% | Lab A |
| 5 Nov 2025 | KPV Oral | 9.6 | 20mg | 17.2mg | -14.2% | 96.16% | Lab A |
| 5 Nov 2025 | Selank 10mg + Semax 10mg Blend | 5.7 | 10mg | 12.2mg | +21.7% | 95.28% | Lab C |
| 5 Nov 2025 | Selank 10mg + Semax 10mg Blend | 5.8 | 5mg | 5.9mg | +18.1% | 97.82% | Lab B |
| 4 Nov 2025 | Selank | 8.8 | 10mg | 12.2mg | +22.3% | 98.68% | Lab E |
| 9 Oct 2025 | Oxytocin Acetate | 7.0 | 30mg | 28.0mg | -6.6% | 96.36% | Lab F |
| 3 Oct 2025 | Abaloparatide | 6.6 | 10mg | 10.8mg | +7.9% | 96.37% | Lab F |
| 3 Oct 2025 | Winstrol (Stanozolol) | 4.9 | 10mg | 11.3mg | +13.0% | 95.48% | Lab E |
| 7 May 2025 | PT-141 | 7.0 | 10mg | 11.9mgwebsite | 10.48mg | 07-24-0710G | |
| 7 May 2025 | PT-141 | 6.9 | 10mg | 11.9mgwebsite | 10.55mg | 07-24-0710G | |
| 16 Mar 2025 | PT-141 | 5.9 | 10mg | 11.9mgwebsite | 10.58mg | 07-24-0710G | |
| 16 Mar 2025 | PT-141 | 6.4 | 10mg | 11.9mgwebsite | 10.88mg | 07-24-0710G | |
| 21 Feb 2025 | CJC-1295 | No DAC | 6.6 | 5mg | 5.6mgwebsite | 5.59mg | 07-24-0505E |
| 19 Feb 2025 | BPC-157 | 9.0 | 10mg | 11.4mgwebsite | 10.91mg | 11-24-0510E | |
| 19 Feb 2025 | CJC-1295 | No DAC | 6.5 | 5mg | 5.6mgwebsite | 5.3mg | 07-24-0505E |